# OptimumBank Holdings, Inc.: overview OPHC · NYSE · CIK 1288855 · [Financials](/sectors/financials.md) · fiscal year ends Dec 31 Pages: [Overview](/companies/ophc.md) · [Financials](/companies/ophc/financials.md) · [Filings](/companies/ophc/filings.md) · [Insiders](/companies/ophc/insiders.md) Revenue is not reported in this company’s XBRL financial statements. ## Last eight quarters | Line item | Unit | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | | --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | | Revenue | $k | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | | Gross margin | % | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | | Operating margin | % | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | | Net margin | % | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | | Diluted EPS | $ per share | [0.15](/filings/0001493152-25-021417.md) | not reported | [0.17](/filings/0001493152-26-022399.md) | [0.15](/filings/0001493152-26-036825.md) | [0.18](/filings/0001493152-25-021417.md) | not reported | [0.20](/filings/0001493152-26-022399.md) | [0.28](/filings/0001493152-26-036825.md) | | Free cash flow | $k | [3,856 d](/filings/0001493152-25-021417.md) | [5,739 d](/filings/0001493152-26-008143.md) | [2,852](/filings/0001493152-26-022399.md) | [5,859 d](/filings/0001493152-26-036825.md) | [1,909 d](/filings/0001493152-25-021417.md) | [6,325 d](/filings/0001493152-26-008143.md) | [7,431](/filings/0001493152-26-022399.md) | [9,808 d](/filings/0001493152-26-036825.md) | - Revenue. XBRL not reported. - Gross margin (gross profit / revenue). XBRL not reported. - Operating margin (operating income / revenue). XBRL not reported. - Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss. Derived values: 12-month figure less the 9-month figure. - Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted. - Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. Derived values: 9-month figure less the 6-month figure; 12-month figure less the 9-month figure; 6-month figure less the 3-month figure. ## Last five fiscal years | Line item | Unit | FY2021 (2021-12-31) | FY2022 (2022-12-31) | FY2023 (2023-12-31) | FY2024 (2024-12-31) | FY2025 (2025-12-31) | | --- | --- | ---: | ---: | ---: | ---: | ---: | | Revenue | $m | not reported | not reported | not reported | not reported | not reported | | Gross margin | % | not reported | not reported | not reported | not reported | not reported | | Operating margin | % | not reported | not reported | not reported | not reported | not reported | | Net margin | % | not reported | not reported | not reported | not reported | not reported | | Diluted EPS | $ per share | [1.61](/filings/0001493152-22-006303.md) | [0.68](/filings/0001493152-24-009360.md) | [0.87](/filings/0001493152-25-008332.md) | [0.63](/filings/0001493152-26-008143.md) | [0.71](/filings/0001493152-26-008143.md) | | Free cash flow | $m | [3.4](/filings/0001493152-23-006772.md) | [10.0](/filings/0001493152-24-009360.md) | [6.2](/filings/0001493152-25-008332.md) | [14.6](/filings/0001493152-26-008143.md) | [16.9](/filings/0001493152-26-008143.md) | - Revenue. XBRL not reported. - Gross margin (gross profit / revenue). XBRL not reported. - Operating margin (operating income / revenue). XBRL not reported. - Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss. - Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareBasicAndDiluted; Diluted EPS: us-gaap:EarningsPerShareDiluted. - Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. Each value links to the filing it came from. d marks a derived value. A ratio is not reported when any input is missing. ## Insider purchases and sales The last 20 open-market transactions on Form 4 (codes P and S). Reported price is as stated on the form, not a market price. [All insider transactions](/companies/ophc/insiders.md) None in coverage. ## Funds that report holding it From each manager’s latest Form 13F, largest reported value first. Reported value is as filed: filing data, not a price. [All funds](/funds.md) | Fund | Quarter ended | Reported value | Shares | Put or call | Change on the quarter before | | --- | --- | ---: | ---: | --- | --- | | [ALLIANCEBERNSTEIN L.P.](/funds/1109448.md) | 2026-06-30 | $3.1m | 616,168 | | Added +32,433 | | [WELLINGTON MANAGEMENT GROUP LLP](/funds/902219.md) | 2026-06-30 | $2.5m | 431,634 | | New +431,634 | | [VANGUARD CAPITAL MANAGEMENT LLC](/funds/2100119.md) | 2026-06-30 | $2.4m | 406,480 | | Added +62,337 | | [RENAISSANCE TECHNOLOGIES LLC](/funds/1037389.md) | 2026-06-30 | $905.5k | 155,051 | | Added +30,451 | | [GEODE CAPITAL MANAGEMENT, LLC](/funds/1214717.md) | 2026-06-30 | $629.8k | 107,840 | | Added +28,355 | | [MORGAN STANLEY](/funds/895421.md) | 2026-06-30 | $584.0k | 100,002 | | Unchanged | | [Mink Brook Asset Management LLC](/funds/2052205.md) | 2026-06-30 | $458.7k | 78,552 | | New +78,552 | | [DIMENSIONAL FUND ADVISORS LP](/funds/354204.md) | 2026-06-30 | $453.5k | 77,662 | | Added +6,175 | | [Sparta 24 Ltd.](/funds/1967706.md) | 2026-06-30 | $428.9k | 73,443 | | New +73,443 | | [VANGUARD FIDUCIARY TRUST CO](/funds/933478.md) | 2026-06-30 | $357.7k | 61,244 | | Added +4,267 | ## Recent filings [All 382 filings](/companies/ophc/filings.md) | Filed | Accepted | Form | What it is | Accession | | --- | --- | --- | --- | --- | | 2026-08-19 | 16:43 ET | [8-K](/filings/0001493152-26-039232.md) | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-26-039232 | | 2026-08-13 | 09:00 ET | [8-K](/filings/0001493152-26-037611.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-26-037611 | | 2026-08-10 | 14:18 ET | [10-Q](/filings/0001493152-26-036825.md) | Quarterly report, period 2026-06-30 | 0001493152-26-036825 | | 2026-07-24 | 08:00 ET | [8-K](/filings/0001493152-26-034476.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-26-034476 | | 2026-05-12 | 08:01 ET | [10-Q](/filings/0001493152-26-022399.md) | Quarterly report, period 2026-03-31 | 0001493152-26-022399 | | 2026-05-05 | 09:00 ET | [8-K](/filings/0001493152-26-021238.md) | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001493152-26-021238 | | 2026-05-04 | 09:00 ET | [8-K](/filings/0001493152-26-021029.md) | 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001493152-26-021029 | | 2026-04-24 | 08:31 ET | [8-K](/filings/0001493152-26-018855.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-26-018855 | | 2026-03-26 | 14:58 ET | [DEF 14A](/filings/0001493152-26-012875.md) | Proxy statement, period 2026-03-26 | 0001493152-26-012875 | | 2026-02-26 | 10:46 ET | [10-K](/filings/0001493152-26-008143.md) | Annual report, period 2025-12-31 | 0001493152-26-008143 | ## Latest annual report [Form 10-K for the fiscal year ended Dec 31, 2025](/filings/0001493152-26-008143.md), filed Feb 26, 2026. ## Forecast league Not in this season’s league. [This season’s league](/leagues.md) ## About the filer - CIK: 1288855 - Tickers: OPHC - Exchange: NYSE - SIC code: 6021 National Commercial Banks - State of incorporation: FL - Filer category: Non-accelerated filer
Smaller reporting company Source: SEC EDGAR, XBRL company facts, the filing index and Forms 4. Last ingested by Listed: Oct 24, 2026, 15:36 ET. No prices; not investment advice.